Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Lee, Ju Hye ^a   Kishikawa, Mutsumi ^a   Kumazoe, Motofumi ^a   Yamada, Koji ^a   Tachibana, Hirofumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; LAMININ RECEPTOR; POLYPHENOL; RECEPTOR ANTIBODY; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; C57BL 6 MOUSE; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; DRUG STRUCTURE; FOOD INTAKE; GENE SILENCING; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA INTERFERENCE; SUBCUTANEOUS TISSUE TUMOR; TEA; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; DRUG SYNERGISM; FLAVONOIDS; HUMANS; MELANOMA, EXPERIMENTAL; PHENOLS; POLYPHENOLS; RECEPTORS, LAMININ; TEA; UP-REGULATION; VITAMIN A;

MUS;

EID: 77956202733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011051     Document Type: Article

References (42)

1. Sang S, Lee MJ, Hou Z, Ho CT, Yang CS (2005) Stability of tea polyphenol (2)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J Agric Food Chem 53: 9478-9484.
2. Lin YL, Juan IM, Chen YL, Liang YC, Lin JK (1996) Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with antiproliferative actions in fibroblast cells. J Agric Food Chem 44: 1387-1394.
3. Wang ZY, Cheng SJ, Zhou ZC, Athar M, Khan WA, et al. (1989) Antimutagenic activity of green tea polyphenols. Mutat Res 223: 273-285.
4. Lin YL, Lin JK (1997) (2)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 52: 465-472.
5. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9: 429-439.
6. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, et al. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7: 351-354.
7. Lee MJ, Wang ZY, Li H, Chen L, Sun Y, et al. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4: 393-399.
8. Fujiki H, Suganuma M, Imai K Nakachi K (2002) Green tea: cancer preventive beverage and/or drug. Cancer Lett 188: 9-13.
9. Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, et al. (2009) Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65: 331-341.
10. Fujimura Y, Yamada K, Tachibana H (2005) A lipid raft-associated 67-kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FceRI expression. Biochem Biophys Res Commun 336: 674-681.
11. Fujimura Y, Umeda D, Yamada K, Tachibana H (2006) The involvement of the 67-kDa laminin receptor-mediated modulation of cytoskeleton in the degranulation inhibition induced by epigallocatechin-3-O-gallate. Biochem Biophys Res Commun 348: 524-531.
12. Umeda D, Tachibana H, Yamada K (2005) Epigallocatechin-3-O-gallate disrupts stress fibers and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67-kDa laminin receptor. Biochem Biophys Res Commun 333: 628-635.
13. Fujimura Y, Umeda D, Yano S, Maeda-Yamamoto M, Yamada K, et al. (2007) The 67-kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG. Biochem Biophys Res Commun 364: 79-85.
14. Yano S, Fujimura Y, Umeda D, Miyase T, Yamada K, et al. (2007) Relationship between the Biological Activities of Methylated Derivatives of (2)-Epigallocatechin- 3-O-gallate (EGCG) and Their Cell Surface Binding Activities. J Agric Food Chem 55: 7144-7148.
15. Fujimura Y, Tachibana H, Yamada K (2004) Lipid raft-associated catechin suppresses the FceRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2. FEBS Lett 556: 204-210.
16. Tachibana H, Koga K, Fujimura Y, Yamada K (2004) A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11: 380-381.
17. Menard S, Castronovo V, Tagliabue E, Sobel ME (1997) New insights into the metastasis-associated 67-kD laminin receptor. J Cell Biochem 67: 155-165.
18. Umeda D, Yano S, Yamada K, Tachibana H (2008) Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 283: 3050-3058.
19. Ozer EA, Kumral A, Ozer E (2005) Effect of retinoic acid on oxygen induced lung injury in the newborn rat. Pediatr Pulmonol 39: 35-40.
20. Gudas LJ, Sporn MB, Roberts AB (1994) Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, eds. The retinoids: biology, chemistry and medicine, 2nd edition. New York: Raven Press. pp 443-520.
21. Xia L, Wurmbach E, Waxman S, Jing Y (2006) Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis. Leukemia 20: 1009-1016.
22. Haque A, Banik NL, Ray SK (2007) Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res 32: 2203-2209.
23. Giguere V, Ong ES, Segui P, Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330: 624-629.
24. Petkovich M, Brand NJ, Krust A, Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444-450.
25. Zhao J, Qi Q, Yang Y, Gu HY, Lu N, et al. (2008) Inhibition of alpha(4) integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid. Eur J Pharmacol 589: 127-31.
26. Bastien J, Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16.
27. Martin PJ, Lardeux V, Lefebvre P (2005) The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct proteinprotein interaction. Nucleic Acids Res 33: 4311-4321.
28. Galati G, Lin A, Sultan AM, O'Brien PJ (2006) Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med 40: 570-580.
29. Jimenez-Saenz M, Martinez-Sanchez Mdel C (2006) Acute hepatitis associated with the use of green tea infusions. J Hepatol 44: 616-617.
30. Bollag W, Holdener EE (1992) Retinoids in cancer prevention and therapy. Ann Oncol 3: 513-526.
31. Tallman MS, Wiernik PH (1992) Retinoids in cancer treatment. J Clin Pharmacol 32: 868-888.
32. Lippman SM, Heyman RA, Kurie JM (1995) Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem 22(suppl): 1-10.
33. Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH, Jr. (2003) Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood 102: 237-245.
34. Huang H, Wu D, Fu J, Chen G, Chang W, et al. (2009) All-trans retinoid acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells. Eur J Haematol 83: 191-202.
35. Karmakar S, Banik NL, Ray SK (2007) Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografis in nude mice. Cancer 112: 596-607.
36. Ozpolat B, Lopez-Berestein G, Adamson P, Fu CJ, Williams AH (2003) Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J Pharm Pharm Sci 6: 292-301.
37. Martignone S, Ménard S, Bufalino R, Cascinelli N, Pellegrini R, et al. (1993) Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 85: 398-402.
38. Ménard S, Tagliabue E, Colnaghi MI (1998) The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 52: 137-145.
39. Lancillotti F, Darwiche N, Celli G, De Luca LM (1992) Retinoid status and the control of keratin expression and adhesion during the histogenesis of squamous metaplasia of tracheal epithelium. Cancer Res 52: 6144-6152.
40. Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP (2010) Epigallocatechin- 3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. Br J Haematol 149: 55-64.
41. Okada N, Tanabe H, Tazoe H, Ishigami Y, Fukutomi R, Yasui K, et al. (2009) Differentiation-associated alteration in sensitivity to apoptosis induced by (2)- epigallocatechin-3-O-gallate in HL-60 cells. Biomed Res 30: 201-206.
42. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129: 723-733.